Latest news with #DHEA
Scottish Sun
9 hours ago
- Entertainment
- Scottish Sun
Paul Pogba ‘agrees deal with next club' as ex-Man Utd star posts cryptic four-word message about return to football
The midfielder looks set for a new league after his rumoured agreement POGBA-CK Paul Pogba 'agrees deal with next club' as ex-Man Utd star posts cryptic four-word message about return to football Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) PAUL POGBA appeared to drop a massive hint on his future after posting a picture wearing a REAL MADRID shirt alongside a cryptic message. Pogba, 32, is still without a team after agreeing the mutual termination of his contract at Juventus in November following his 18-month doping ban - but has now reportedly agreed terms with his next club. Sign up for Scottish Sun newsletter Sign up 7 Paul Pogba has shared pictures of him training in a Real Madrid shirt Credit: 7 Fans are convinced that the shirt is a hint at Pogba's future Credit: 7 Pogba was working out with NFL star Tyreek Hill Credit: 7 Pogba is still without a club after his 18-month doping ban came to an end Credit: The former Manchester United midfielder was slapped with an initial four-year ban for taking banned substance DHEA last year, but saw that punishment slashed to just 18 months after a successful appeal to the Court of Arbitration of Sport. Pogba has been able to return to football since March following the end of his ban. Now it looks like the World Cup winner has dropped a hint over where he could be heading next, after he posted photos of himself training in a Real Madrid shirt alongside the caption: "I think it's time". Fans are convinced that the cryptic post is confirmation that Pogba will be heading to the Bernabeu to join Madrid ahead of the new campaign. READ MORE IN FOOTBALL FOOTBALL TRAGEDY Three football fans dead & at least 70 injured in stadium disaster One wrote: "Pogba to Real Madrid - HERE WE GO". While another added: "Welcome to Real Madrid". A third commented: "Time to join Real Madrid". And a fourth posted: "Hope it's time for you to join Real Madrid". 7 Pogba has agreed a deal with a new club, according to reports Credit: 7 The Frenchman is unlikely to join Real Madrid Credit: CASINO SPECIAL - BEST CASINO BONUSES FROM £10 DEPOSITS However, a switch to Madrid seems unlikely in reality - with reports suggesting that Pogba has already agreed a move to Ligue 1 club Monaco as his return to football. It's claimed by French outlet Le Parisien that Pogba will pen a two-year deal with Monaco ahead of the new campaign. 'I take responsibility but...' - Paul Pogba breaks silence as ex-Man Utd star gives first interview since doping ban The 91-time France international insisted he was still able to play at the top level in an interview in October, eyeing a return to the national team. He said: "That's what I hope [to play for France]. It's in my mind for sure but I have to be ready for that. "There's players there that deserve to be playing and deserve to be in the national team. "I have to win my place back in the team again."
Daily Mail
6 days ago
- Sport
- Daily Mail
Paul Pogba reunites with former Man United team-mates at Club World Cup as he continues hunt for new club after return from doping ban
Paul Pogba reunited with some former Manchester United team-mates at the Club World Cup as he continues his hunt for his next club after his return from a doping ban. In the Court of Arbitration for Sport's final judgement it was confirmed that Pogba did inadvertently take DHEA, a substance that boosts testosterone that is on WADA's banned list. Crucially, however, the ruling states that DHEA only has an affect on females. Pogba was facing potential retirement from football had CAS upheld his four-year suspension, but his ban was lifted in March and he is now free to play football again. The midfielder does, though, remain without a club and is yet to decide his future despite being linked with a number of sides in recent months. In a break from that, though, the 31-year-old jetted out to the States to catch up with some old friends in Miami as River Plate took on Benfica. Taking to Instagram, Pogba, who captioned the photo: 'What a pleasure to see my friends!' shared a snap of himself and four other former United players after they had just played for River Plate in their first Club World Cup match. Sharing to his story and his 63million followers, Pogba stood in the middle of the group with his arms around two of the players. To his left was goalkeeper Sergio Romero, who played 61 times for United - 21 times alongside Pogba - between 2015 and 2021. To his right was forward Edinson Cavani. The former Paris Saint-Germain man played 59 times for United - 36 with Pogba - joining in 2020 and leaving in 2022. Next to Romero was Marcos Rojo. The centre back played for United for seven years, playing 48 times alongside the World Cup winner. The final man in the picture was Ander Herrera, who payed alongside Pogba 84 times - and was sent off in the game despite not being on the pitch. The 35-year-old tried to shove his way through security and approach the referee while he was in the middle of a VAR review just before half-time. Herrera was stopped and shown a red card by referee Cesar Arturo Ramos when he was made aware of the reckless behaviour of the midfielder. He had already been substituted in the 20th minute after picking up an injury, but was seething on the sidelines at the perceived injustice of a decision against the Argentinian side. None of the former United players scored in the 2-2 draw, but Angel Di Maria, who played for United for less than a year between 2014 and 2015, netted for Benfica.
Time of India
02-06-2025
- Health
- Time of India
PGI researchers give new hope for treatment of severe liver disease
Lucknow: Advanced scientific research conducted by scientists at Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS) has shown a new way to treat Non-Alcoholic Steatohepatitis (NASH) – a severe but common liver disease. Tired of too many ads? go ad free now The research, led by Rohit A Sinha, a scientist and associate professor in the endocrinology department, along with his team comprising Sana Raza and Pratima Gupta, proved that a naturally occurring hormone called dehydroepiandrosterone (DHEA) can help in checking liver damage caused by NASH by removing harmful fat from liver cells, reducing inflammation, and preventing liver damage. A Union health ministry document notes that NASH is the severest form of Non-Alcoholic Fatty Liver Disease (NAFLD). Terming it as "a silent epidemic", the document noted that NAFLD's community prevalence ranges from 9% to 32%, depending on age, gender, area of residence, and socioeconomic status. This means that up to three people out of 10 could have fatty liver or a related disease. What raises concerns is that 20% of people with NAFLD develop NASH. "DHEA is a parent hormone that acts as a precursor to sex hormones in humans. While scanning several case studies of NASH patients, we noted that the level of DHEA in them was on the lower side. Keeping this as the base, we proposed to study the impact of increasing this hormone in NASH patients with a significant extent of fibrosis – a symptom of NASH," said Sinha, adding that the study was published in the journal 'Molecular and Cellular Endocrinology'. "We began with animal studies. In the mouse model, we fed the experimental group with a NASH-inducing diet. When the condition was confirmed in them, we injected DHEA. The outcome showed that the severity of liver damage in 80% of the sample decreased by about 60%," he said. The results paved the way for a cellular study in which the researchers worked upon lab-grown human liver cells. "Here too, in the experimental group, we loaded the cells with excessive fat to create a NASH-like condition. Thereafter, we introduced DHEA and found that the fat percentage decreased by up to 80%," said Sinha. "The result has been heartening. We now look forward to clinical trials for hormone replacement therapy," he said.
NDTV
01-06-2025
- Health
- NDTV
Abortion Pill Inventor Etienne-Emile Baulieu Dies At 98
Rome: French scientist Etienne-Emile Baulieu, best known as the inventor of the abortion pill, died on Friday aged 98 at his home in Paris, his institute said in a statement. Both a doctor and a researcher, Baulieu was known around the world for the scientific, medical and social significance of his work on steroid hormones. "His research was guided by his attachment to the progress made possible by science, his commitment to women's freedom, and his desire to enable everyone to live better, longer lives," the Institut Baulieu said in the statement posted on its website. Born Etienne Blum in Strasbourg on Dec. 12, 1926, he took the name "Emile Baulieu" when he joined the French Resistance against the Nazi occupation at the age of 15. An endocrinologist with a doctorate in medicine completed in 1955 and one in science eight years later, in 1963 Baulieu founded a pioneering research unit working on hormones at INSERM, the French institute for health and medical research. He remained as head of the unit until 1997. He is best known for his development, in 1982, of RU 486, the so-called "abortion pill" that changed the lives of millions of women throughout the world, offering them the possibility of voluntary medical termination of pregnancy, in physical and psychological safety. The Institut Baulieu said it was "a non-invasive method, less aggressive and less delayed than surgery," noting that following his discovery the researcher faced fierce criticism and even threats from opponents of women's abortion rights. "Even today, access to this method is opposed, banned in some countries, and is currently being challenged in the United States, where it is the most widely used abortion method," the institute added. Baulieu's research into DHEA, a hormone whose secretion and anti-aging activity he had discovered, led him to work on neurosteroids -- or steroids of the nervous system. He also developed an original treatment to combat depression, for which a clinical trial is currently underway in several university hospitals. In 2008, he founded the Institut Baulieu to understand, prevent and treat neurodegenerative diseases such as Alzheimer's. Honored with the grand crosses of the Légion d'honneur (legion of honor) and the Ordre national du Mérite (national order of merit), he was elected to the French Academy of Sciences in 1982, which he chaired in 2003 and 2004. He was a member of the national advisory committee on life sciences and health (1996-2002) and received numerous awards, both in France and abroad. French President Emmanuel Macron paid tribute to Baulieu in a post on X, calling him "a beacon of courage" and "a progressive mind who enabled women to win their freedom." "Few French people have changed the world to such an extent," he added. After the death of his first wife, Yolande Compagnon, he remarried, to Simone Harari Baulieu. He is survived by three children, eight grandchildren and nine great-grandchildren, his institute said.
The Advertiser
31-05-2025
- Health
- The Advertiser
French inventor of the abortion pill dies at 98
French scientist Etienne-Emile Baulieu, best known as the inventor of the abortion pill RU 486, has died aged 98 at his home in Paris. Both a doctor and a researcher, Baulieu was known around the world for the scientific, medical and social significance of his work on steroid hormones. "His research was guided by his attachment to the progress made possible by science, his commitment to women's freedom, and his desire to enable everyone to live better, longer lives," Institut Baulieu said in the statement posted on its website. Born Etienne Blum in Strasbourg on December 12, 1926, he took the name "Émile Baulieu" when he joined the French Resistance against the Nazi occupation at the age of 15. An endocrinologist with a doctorate in medicine completed in 1955 and one in science eight years later, in 1963 Baulieu founded a pioneering research unit working on hormones at INSERM, the French institute for health and medical research. He remained as head of the unit until 1997. He is best known for his development, in 1982, of RU 486, the so-called "abortion pill" that changed the lives of millions of women throughout the world, offering them the possibility of voluntary medical termination of pregnancy, in physical and psychological safety. The Institut Baulieu said it was "a non-invasive method, less aggressive and less delayed than surgery," noting that following his discovery, the researcher faced fierce criticism and even threats from opponents of women's abortion rights. "Even today, access to this method is opposed, banned in some countries, and is currently being challenged in the United States, where it is the most widely used abortion method," the institute said. Baulieu's research into DHEA, a hormone whose secretion and anti-aging activity he had discovered, led him to work on neurosteroids -- or steroids of the nervous system. He also developed an original treatment to combat depression, for which a clinical trial is currently underway in several university hospitals. In 2008, he founded the Institut Baulieu to understand, prevent and treat neurodegenerative diseases such as Alzheimer's. Honoured with the grand crosses of the Légion d'honneur (legion of honour) and the Ordre national du Mérite (national order of merit), he was elected to the French Academy of Sciences in 1982, which he chaired in 2003 and 2004. He was a member of the national advisory committee on life sciences and health (1996-2002) and received numerous awards, both in France and abroad. French President Emmanuel Macron paid tribute to Baulieu in a post on X, calling him "a beacon of courage" and "a progressive mind who enabled women to win their freedom". "Few French people have changed the world to such an extent," he said. After the death of his first wife, Yolande Compagnon, he remarried, to Simone Harari Baulieu. He is survived by three children, eight grandchildren and nine great-grandchildren. French scientist Etienne-Emile Baulieu, best known as the inventor of the abortion pill RU 486, has died aged 98 at his home in Paris. Both a doctor and a researcher, Baulieu was known around the world for the scientific, medical and social significance of his work on steroid hormones. "His research was guided by his attachment to the progress made possible by science, his commitment to women's freedom, and his desire to enable everyone to live better, longer lives," Institut Baulieu said in the statement posted on its website. Born Etienne Blum in Strasbourg on December 12, 1926, he took the name "Émile Baulieu" when he joined the French Resistance against the Nazi occupation at the age of 15. An endocrinologist with a doctorate in medicine completed in 1955 and one in science eight years later, in 1963 Baulieu founded a pioneering research unit working on hormones at INSERM, the French institute for health and medical research. He remained as head of the unit until 1997. He is best known for his development, in 1982, of RU 486, the so-called "abortion pill" that changed the lives of millions of women throughout the world, offering them the possibility of voluntary medical termination of pregnancy, in physical and psychological safety. The Institut Baulieu said it was "a non-invasive method, less aggressive and less delayed than surgery," noting that following his discovery, the researcher faced fierce criticism and even threats from opponents of women's abortion rights. "Even today, access to this method is opposed, banned in some countries, and is currently being challenged in the United States, where it is the most widely used abortion method," the institute said. Baulieu's research into DHEA, a hormone whose secretion and anti-aging activity he had discovered, led him to work on neurosteroids -- or steroids of the nervous system. He also developed an original treatment to combat depression, for which a clinical trial is currently underway in several university hospitals. In 2008, he founded the Institut Baulieu to understand, prevent and treat neurodegenerative diseases such as Alzheimer's. Honoured with the grand crosses of the Légion d'honneur (legion of honour) and the Ordre national du Mérite (national order of merit), he was elected to the French Academy of Sciences in 1982, which he chaired in 2003 and 2004. He was a member of the national advisory committee on life sciences and health (1996-2002) and received numerous awards, both in France and abroad. French President Emmanuel Macron paid tribute to Baulieu in a post on X, calling him "a beacon of courage" and "a progressive mind who enabled women to win their freedom". "Few French people have changed the world to such an extent," he said. After the death of his first wife, Yolande Compagnon, he remarried, to Simone Harari Baulieu. He is survived by three children, eight grandchildren and nine great-grandchildren. French scientist Etienne-Emile Baulieu, best known as the inventor of the abortion pill RU 486, has died aged 98 at his home in Paris. Both a doctor and a researcher, Baulieu was known around the world for the scientific, medical and social significance of his work on steroid hormones. "His research was guided by his attachment to the progress made possible by science, his commitment to women's freedom, and his desire to enable everyone to live better, longer lives," Institut Baulieu said in the statement posted on its website. Born Etienne Blum in Strasbourg on December 12, 1926, he took the name "Émile Baulieu" when he joined the French Resistance against the Nazi occupation at the age of 15. An endocrinologist with a doctorate in medicine completed in 1955 and one in science eight years later, in 1963 Baulieu founded a pioneering research unit working on hormones at INSERM, the French institute for health and medical research. He remained as head of the unit until 1997. He is best known for his development, in 1982, of RU 486, the so-called "abortion pill" that changed the lives of millions of women throughout the world, offering them the possibility of voluntary medical termination of pregnancy, in physical and psychological safety. The Institut Baulieu said it was "a non-invasive method, less aggressive and less delayed than surgery," noting that following his discovery, the researcher faced fierce criticism and even threats from opponents of women's abortion rights. "Even today, access to this method is opposed, banned in some countries, and is currently being challenged in the United States, where it is the most widely used abortion method," the institute said. Baulieu's research into DHEA, a hormone whose secretion and anti-aging activity he had discovered, led him to work on neurosteroids -- or steroids of the nervous system. He also developed an original treatment to combat depression, for which a clinical trial is currently underway in several university hospitals. In 2008, he founded the Institut Baulieu to understand, prevent and treat neurodegenerative diseases such as Alzheimer's. Honoured with the grand crosses of the Légion d'honneur (legion of honour) and the Ordre national du Mérite (national order of merit), he was elected to the French Academy of Sciences in 1982, which he chaired in 2003 and 2004. He was a member of the national advisory committee on life sciences and health (1996-2002) and received numerous awards, both in France and abroad. French President Emmanuel Macron paid tribute to Baulieu in a post on X, calling him "a beacon of courage" and "a progressive mind who enabled women to win their freedom". "Few French people have changed the world to such an extent," he said. After the death of his first wife, Yolande Compagnon, he remarried, to Simone Harari Baulieu. He is survived by three children, eight grandchildren and nine great-grandchildren. French scientist Etienne-Emile Baulieu, best known as the inventor of the abortion pill RU 486, has died aged 98 at his home in Paris. Both a doctor and a researcher, Baulieu was known around the world for the scientific, medical and social significance of his work on steroid hormones. "His research was guided by his attachment to the progress made possible by science, his commitment to women's freedom, and his desire to enable everyone to live better, longer lives," Institut Baulieu said in the statement posted on its website. Born Etienne Blum in Strasbourg on December 12, 1926, he took the name "Émile Baulieu" when he joined the French Resistance against the Nazi occupation at the age of 15. An endocrinologist with a doctorate in medicine completed in 1955 and one in science eight years later, in 1963 Baulieu founded a pioneering research unit working on hormones at INSERM, the French institute for health and medical research. He remained as head of the unit until 1997. He is best known for his development, in 1982, of RU 486, the so-called "abortion pill" that changed the lives of millions of women throughout the world, offering them the possibility of voluntary medical termination of pregnancy, in physical and psychological safety. The Institut Baulieu said it was "a non-invasive method, less aggressive and less delayed than surgery," noting that following his discovery, the researcher faced fierce criticism and even threats from opponents of women's abortion rights. "Even today, access to this method is opposed, banned in some countries, and is currently being challenged in the United States, where it is the most widely used abortion method," the institute said. Baulieu's research into DHEA, a hormone whose secretion and anti-aging activity he had discovered, led him to work on neurosteroids -- or steroids of the nervous system. He also developed an original treatment to combat depression, for which a clinical trial is currently underway in several university hospitals. In 2008, he founded the Institut Baulieu to understand, prevent and treat neurodegenerative diseases such as Alzheimer's. Honoured with the grand crosses of the Légion d'honneur (legion of honour) and the Ordre national du Mérite (national order of merit), he was elected to the French Academy of Sciences in 1982, which he chaired in 2003 and 2004. He was a member of the national advisory committee on life sciences and health (1996-2002) and received numerous awards, both in France and abroad. French President Emmanuel Macron paid tribute to Baulieu in a post on X, calling him "a beacon of courage" and "a progressive mind who enabled women to win their freedom". "Few French people have changed the world to such an extent," he said. After the death of his first wife, Yolande Compagnon, he remarried, to Simone Harari Baulieu. He is survived by three children, eight grandchildren and nine great-grandchildren.
